12/10/2013
https://www.congress.gov...
"It's a disturbing day when I think that the argument is, provide us more money and we'll do a better job."
"If we don't have measurement tools to determine whether a fee system produces a better outcome, then I'm not sure why we would sign off on it as policymakers."
"I'm very concerned about the strength of the U.S. industry, the ability of American companies to deliver the products, drugs and devices that the American people need."
"But is it the agency's policy to ignore the statute in the law?"